ESCITALOPRAM OXALATE
NDC 43602-475, escitalopram, tablet, from Ascent Pharmaceuticals, Inc.
- Product NDC
- 43602-475
- Status
- Listed
- Labeler
- Ascent Pharmaceuticals, Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215177
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43602-475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ESCITALOPRAM OXALATE20 mg/1
Pharmacologic classes
Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43602-475-10 | 43602047510 | 1000 TABLET in 1 BOTTLE (43602-475-10) |
| 43602-475-30 | 43602047530 | 30 TABLET in 1 BOTTLE (43602-475-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1285841d-d9f8-49c6-9456-bf51c8e37271
Use it
Look up 43602-475 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43602-475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43602-475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.